Jump to Main-Site Navigation
About Santarus
Santarus, Inc. is a specialty biopharmaceutical company focused on acquiring, developing and commercializing
proprietary products that address the needs of patients treated by physician specialists.
Learn More
Products
Gastroenterology
UCERIS™ (budesonide) extended release tablets for the induction of remission in active, mild to moderate ulcerative colitis. UCERIS contains budesonide, a locally acting corticosteroid, in a novel oral tablet formulation that utilizes proprietary MMX® multi-matrix system colonic delivery technology.
ZEGERID® (omeprazole/sodium bicarbonate) is an immediate-release oral proton pump inhibitor (PPI) used in adults to treat heartburn and other symptoms that happen with gastroesophageal reflex disease (GERD).
Back to Top
|
|
Endocrinology
GLUMETZA® (metformin hydrochloride extended release tablets) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. As with all metformin products, GLUMETZA has a boxed warning for lactic acidosis. Please click here for Important Safety Information and Full Prescribing Information, including boxed warning.
CYCLOSET® (bromocriptine mesylate) is a first-in-class antidiabetic treatment that may lower your blood sugar, without increasing insulin.
FENOGLIDE® is a fenofibrate prescribed to treat adults with hyperlipidemia (high cholesterol in the blood), mixed dyslipidemia (a combination of high Low-density lipoprotein (LDL) cholesterol, high triglycerides, and low High-density lipoprotein (HDL) cholesterol), or hypertriglyceridemia (high triglyceride levels in the blood) in combination with eating a healthy diet low in saturated fat and cholesterol.
|
Jump to Content
